Intrauterine devices may lower risk of cervical cancer among users, study shows

Contraceptive intrauterine devices (IUDs), also called coils, "might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease," according to a study published Tuesday in the journal Lancet Oncology, Reuters reports. "The results show that coil use did not affect the risk of [human papillomavirus (HPV)] infection, but was linked to a markedly lower risk of cervix cancer for both major types of the disease -- reducing the likelihood of developing squamous-cell carcinoma by 44 percent and adenocarcinoma or adenosquamous carcinoma by 54 percent," the news agency writes.

According to the researchers, "possible explanations for the protective effect of coils could be that the process of inserting or removing them destroys pre-cancerous cells, or that it causes some kind of inflammation that prompts a long-lasting immune response and prevents the HPV from progressing," Reuters says. For the study, researchers "analyzed data from 10 case-control studies of cervical cancer done in eight countries and 16 HPV prevalence surveys in women from four continents," the news agency notes (Kelland, 9/12).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Scientists map cancer mutations in EGFR gene, revealing drug resistance paths